In the past week, SBRA stock has gone up by 2.42%, with a monthly decline of -7.53% and a quarterly plunge of -6.78%. The volatility ratio for the week is 1.56%, and the volatility levels for the last 30 days are 2.27% for Sabra Healthcare REIT Inc The simple moving average for the last 20 days is -0.90% for SBRA stock, with a simple moving average of 5.67% for the last 200 days.
Is It Worth Investing in Sabra Healthcare REIT Inc (NASDAQ: SBRA) Right Now?
Sabra Healthcare REIT Inc (NASDAQ: SBRA) has a price-to-earnings ratio of 41.81x that is above its average ratio. Additionally, the 36-month beta value for SBRA is 1.24. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 0 rating it as “overweight,” 7 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SBRA is 232.73M and currently, short sellers hold a 8.37% ratio of that float. The average trading volume of SBRA on January 01, 2025 was 1.95M shares.
SBRA) stock’s latest price update
The stock of Sabra Healthcare REIT Inc (NASDAQ: SBRA) has increased by 1.64 when compared to last closing price of 17.04. Despite this, the company has experienced a 2.42% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2024-12-31 that With the FED’s rate cut predictions for 2025, Sabra Health Care REIT offers a buying opportunity for long-term investors, especially retirees and income investors. Sabra’s solid fundamentals, including improved occupancy rates and a safe 6% dividend yield, make it an attractive investment despite recent market sell-offs. The REIT’s balance sheet has strengthened, with Moody’s upgrading their outlook to positive, indicating potential for future investment opportunities and price appreciation.
Analysts’ Opinion of SBRA
Many brokerage firms have already submitted their reports for SBRA stocks, with Mizuho repeating the rating for SBRA by listing it as a “Neutral.” The predicted price for SBRA in the upcoming period, according to Mizuho is $20 based on the research report published on December 05, 2024 of the previous year 2024.
Wells Fargo, on the other hand, stated in their research note that they expect to see SBRA reach a price target of $20, previously predicting the price at $16. The rating they have provided for SBRA stocks is “Overweight” according to the report published on October 01st, 2024.
Citigroup gave a rating of “Buy” to SBRA, setting the target price at $20 in the report published on September 13th of the previous year.
SBRA Trading at -5.24% from the 50-Day Moving Average
After a stumble in the market that brought SBRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.53% of loss for the given period.
Volatility was left at 2.27%, however, over the last 30 days, the volatility rate increased by 1.56%, as shares sank -5.72% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.28% lower at present.
During the last 5 trading sessions, SBRA rose by +2.42%, which changed the moving average for the period of 200-days by +22.58% in comparison to the 20-day moving average, which settled at $17.48. In addition, Sabra Healthcare REIT Inc saw 21.37% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SBRA starting from Cusack Catherine, who purchase 7,000 shares at the price of $14.43 back on May 22 ’24. After this action, Cusack Catherine now owns 46,385 shares of Sabra Healthcare REIT Inc, valued at $101,010 using the latest closing price.
FOSTER MICHAEL J, the Director of Sabra Healthcare REIT Inc, sale 10,000 shares at $14.68 during a trade that took place back on May 14 ’24, which means that FOSTER MICHAEL J is holding 63,923 shares at $146,830 based on the most recent closing price.
Stock Fundamentals for SBRA
Current profitability levels for the company are sitting at:
- 0.38 for the present operating margin
- 0.52 for the gross margin
The net margin for Sabra Healthcare REIT Inc stands at 0.14. The total capital return value is set at 0.07. Equity return is now at value 3.46, with 1.81 for asset returns.
Based on Sabra Healthcare REIT Inc (SBRA), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at 0.13. The debt to equity ratio resting at 0.9. The interest coverage ratio of the stock is 2.02.
Currently, EBITDA for the company is 311.81 million with net debt to EBITDA at 5.75. When we switch over and look at the enterprise to sales, we see a ratio of 9.43. The receivables turnover for the company is 5.71for trailing twelve months and the total asset turnover is 0.13.
Conclusion
In conclusion, Sabra Healthcare REIT Inc (SBRA) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
